All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are the long-term effects of COVID-19 in patients with MPN?

During the EHA2021 Virtual Congress, the MPN Hub spoke with Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, IT. We asked, What are the long-term effects of COVID-19 in patients with myeloproliferative neoplasms (MPN)?

What are the long-term effects of COVID-19 in patients with MPN?

In this video, Barbui discusses the findings from a European observational study on the epidemiology of COVID-19 in patients with MPN. The study consisted of 180 patients from European countries and looked at mortality rates and incidence of thrombosis. 

  

Share: